| Literature DB >> 29271538 |
Andreas Metzner1, Erik Wissner1, Alexey Tsyganov2, Vitaly Kalinin3, Michael Schlüter1, Christine Lemes1, Shibu Mathew1, Tilmann Maurer1, Christian-Hendrik Heeger1, Bruno Reissmann1, Feifan Ouyang1, Amiran Revishvili4, Karl-Heinz Kuck1.
Abstract
BACKGROUND: A novel noninvasive epicardial and endocardial electrophysiology system (NEEES) to identify electrical rotors and focal activity in patients with atrial fibrillation (AF) was recently introduced. Comparison of NEEES data with results from invasive mapping is lacking.Entities:
Keywords: atrial fibrillation; noninvasive mapping; phase mapping; rotors
Mesh:
Year: 2017 PMID: 29271538 PMCID: PMC6931819 DOI: 10.1111/anec.12527
Source DB: PubMed Journal: Ann Noninvasive Electrocardiol ISSN: 1082-720X Impact factor: 1.468
Baseline characteristics of atrial fibrillation (AF) patients enrolled in the study
| Patient # | Age | Gender | Diagnosis | Comorbidities | AF duration | AAD | LA, mm | LV EF, % | CHADS2‐VASc Score | Catheter procedure |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 50 | M | Persistent AF | HT, Stroke (TIA) | 6 months | β‐blockers | 46 | 45 | 4 | PVI |
| 2 | 45 | M | Persistent AF | 3 months | β‐blockers | 44 | 55 | 0 | PVI | |
| 3 | 70 | M | Persistent AF | HT, CAD, Stroke (TIA) | 7 months | β‐blockers | 45 | 55 | 4 | PVI |
| 4 | 55 | M | Persistent AF | HT | 4 months | β‐blockers | 46 | 50 | 1 | PVI + roof line + CFAE |
| 5 | 62 | M | Persistent AF | CAD | 5 months | β‐blockers | 56 | 55 | 1 | PVI |
| 6 | 74 | M | Persistent AF | HT, CAD | 1 month | β‐blockers | 54 | 55 | 3 | PVI + roof line |
AAD, antiarrhythmic drugs; CAD, coronary artery disease; CFAE, complex fractioned atrial electrograms; LV EF, left ventricular ejection fraction; HT, arterial hypertension; LA, left atrial diameter; PVI, pulmonary veins isolation; TIA, transient ischemic attack.
Figure 1Typical reentrant excitation patterns during atrial fibrillation (AF) visualized by noninvasive phase mapping. Unclosed phase front (the border between red and purple colors) is seen. The phase singularities, marked by white and black points are located at the front ends. The phase front is rotating around phase singularities forming a pair of rotors with opposite chiralities, rotating clockwise and counterclockwise. At the same time, the phase singularities (rotor cores) meander along the atrial surfaces (near the left atrial appendage [LAA] and at the lateral wall of the right atrium [RA])
Properties of noninvasively determined rotors
| Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
|---|---|---|---|---|---|---|
| Observation time | 20,790 | 17,226 | 19,002 | 22,285 | 20,642 | 23,277 |
| Single pair of PS, msec | 14,059 (67.6%) | 12, 304 (71.4%) | 12,123 (63.8%) | 16,204 (72.7%) | 14,573 (70.6%) | 15,886 (68.3%) |
| Rotor's stability time, msec | 6,374 (30.7%) | 5,778 (33.5%) | 6,249 (32.9%) | 4,823 (21.6%) | 5,072 (24,6%) | 6,996 (30.1%) |
| Rotors, | 44 | 36 | 35 | 30 | 32 | 45 |
| CW rotors, | 27 (64.3) | 19 (52.8) | 12 (34.3) | 14 (46.7) | 17 (53.1) | 16 (35.6) |
| Full rotor rotations, | 1.2 ± 0.4 | 1.1 ± 0.4 | 1.2 ± 0.4 | 1.3 ± 0.6 | 1.3 ± 0.4 | 1.2 ± 0.5 |
| 1 full rotation, | 38 (90.5) | 31 (86.1) | 28 (80.0) | 26 (86.7) | 27 (84.4) | 34 (75.6) |
| 2 full rotations, | 6 (9.5) | 5 (13.9) | 6 (17.1) | 4 (13.3) | 5 (15.6) | 8 (17.8) |
| 3 full rotations, | 0 | 0 | 1 (2.9) | 0 | 0 | 2 (4.4) |
| 4 full rotations, | 0 | 0 | 0 | 0 | 0 | 1 (2.2) |
| Rotor cycle length, msec | 145 ± 18 | 161 ± 22 | 178 ± 24 | 160 ± 15 | 159 ± 19 | 155 ± 11 |
| Meandering distance during 1 cycle, mm | 13.8 ± 5.2 | 15.7 ± 6.1 | 16.4 ± 5.6 | 14.7 ± 4.7 | 15.4 ± 5.3 | 14.8 ± 4.0 |
| Aggregation sites, | 2 | 2 | 2 | 2 | 2 | 3 |
| Rotors at aggregation sites, | 24 (57.1)@ RSPV roof7 (16.7)@ inferoseptal LA | 15 (41.7)@ posterior LA7 (19.5)@ SVC | 15 (42.9)@ LSPV14 (40)@ lateral RA | 14 (46.7)@ posterior LA10 (33.3)@ RSPV | 14 (43.8)@ lateral RA12 (37.5)@ posterior LA | 11 (24.4)@ anterior LA9 (20)@ left post. LA8 (17.8)@ right post. LA |
PS, phase singularity; CW, clockwise; LA, left atrium; LSPV, left superior pulmonary vein; post., posterior; RA, right atrium; RSPV, right superior pulmonary vein; SVC, superior vena cava.
Sum of analyzed TQ intervals.
Figure 2Spatial distribution of rotor cores and focal sources (novel noninvasive epicardial and endocardial electrophysiology system [NEEES]). Most rotors aggregated in few discrete clusters. In five patients two clusters were observed, in one patient three clusters. In two patients (N3 and N6) the focal‐type activation patterns originating from the pulmonary veins were imaged
Observation times, numbers of rotors, and rotor occurrence rates by novel noninvasive epicardial and endocardial electrophysiology system (NEEES) and catheter mapping in selected atrial segments
| Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NEEES | Catheter | NEEES | Catheter | NEEES | Catheter | NEEES | Catheter | NEEES | Catheter | NEEES | Catheter | ||
| LA ant. | Obs. time | 20,790 | – | 17,226 | – | 19,022 | – | 22,285 | – | 20,642 |
| 23,277 | 9,329 |
| Rotors, | 3 | – | 0 | – | 0 | – | 0 | – | 1 |
| 11 | 5 | |
| Occ. rate | 0.14 | – | 0.0 | – | 0.0 | – | 0.0 | – | 0.05 |
| 0.47 | 0.54 | |
| LA roof | Obs. time | 20,790 | 7,931 | 17,226 | 6,908 | 19,022 | 7,620 | 22,285 | 8,470 | 20,642 | 7,988 | 23,277 | 8,861 |
| Rotors, | 7 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | |
| Occ. rate | 0.34 | 0.25 | 0.06 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.09 | 0.23 | |
| LA post. | Obs. time | 20,790 | 8,255 | 17,226 | 7,156 | 19,022 | 7,437 | 22,285 | 8,135 | 20,642 | 8,144 | 23,277 | 9,074 |
| Rotors, | 1 | 0 | 15 | 6 | 1 | 0 | 14 | 4 | 12 | 4 | 17 | 5 | |
| Occ. rate | 0.05 | 0.0 | 0.87 | 0.84 | 0.05 | 0.0 | 0.63 | 0.49 | 0.58 | 0.49 | 0.73 | 0.55 | |
| LA inf. | Obs. time | 20,790 | 8,032 | 17,226 | 7,044 | 19,022 | 7,688 | 22,285 | 8,370 | 20,642 | 7,912 | 23,277 | 9,125 |
| Rotors, | 9 | 3 | 3 | 1 | 2 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | |
| Occ. rate | 0.43 | 0.37 | 0.17 | 0.14 | 0.11 | 0.13 | 0.0 | 0.0 | 0.05 | 0.0 | 0.04 | 0.0 | |
| LSPV | Obs. time | 20,790 | – | 17,226 | – | 19,022 | 7,832 | 22,285 | – | 20,642 | – | 23,277 | – |
| Rotors, | 2 | 1 | – | 15 | 5 | 0 | – | 1 | – | 2 | – | ||
| Occ. rate | 0.10 | – | 0.06 | – | 0.79 | 0.64 | 0.0 | – | 0.05 | – | 0.09 | – | |
| RSPV | Obs. time | 20,790 | 8,324 | 17,226 | – | 19,022 | – | 22,285 | – | 20,642 | – | 23,277 | – |
| Rotors, | 17 | 5 | 3 | – | 0 | – | 10 | – | 0 | – | 2 | – | |
| Occ. rate | 0.82 | 0.60 | 0.17 | – | 0.0 | – | 0.45 | – | 0.0 | – | 0.09 | – | |
| RA lat. | Obs. time | 20,790 | ‐ | 17,226 | – | 19,022 | – | 22,285 | – | 20,642 | 8,346 | 23,277 | – |
| Rotors, | 0 | – | 1 | – | 14 | – | 2 | – | 14 | 6 | 5 | – | |
| Occ. rate | 0.0 | – | 0.06 | – | 0.74 | – | 0.09 | – | 0.68 | 0.72 | 0.22 | – | |
Observation (Obs.) time in msec; Occurrence (Occ.) rate in 1/sec.
ant., anterior; inf., inferior; LA, left atrium; RA, right atrium; LAA, left atrial appendage; lat., lateral; LSPV, left superior pulmonary vein; post., posterior; RSPV, right superior pulmonary vein.
Figure 3Noninvasively and invasively imaged rotors during atrial fibrillation (AF). The phase maps obtained by novel noninvasive epicardial and endocardial electrophysiology system (NEEES) (left‐hand panels) and catheter mapping (middle and right‐hand panels) demonstrated a rotor in a similar atrial location rotating in the same clockwise direction
Figure 4Rotor occurrence rates mapped noninvasively and invasively in atrial segments investigated by both mapping methods
Figure 5Statistical evaluation of rotor occurrence rate measurement. (a) Correlation of rotor occurrence rates as measured by the two techniques. LA, left atrium; LSPV, left superior pulmonary vein; RA, right atrium; RSPV, right superior pulmonary vein. (b) Bland–Altman plot of agreement between measurements of rotor occurrence rate by the two techniques. Mean difference (novel noninvasive epicardial and endocardial electrophysiology system [NEEES] – catheter) is 0.04 per second, with the zone of agreement ranging from −0.117 to 0.197 per second
Properties of rotors in dominant sites of rotor observation
| Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dominant site of rotor observation | RSPV | LA posterior | LSPV | LA posterior | RA lateral | LA anterior | ||||||
| Mapping device | NEEES | Catheter | NEEES | Catheter | NEEES | Catheter | NEEES | Catheter | NEEES | Catheter | NEEES | Catheter |
| Observed rotors, | 17 | 5 | 15 | 6 | 15 | 5 | 15 | 5 | 14 | 6 | 11 | 5 |
| CW rotors, | 7 (41) | 2 (40) | 7 (47) | 2 (33) | 9 (60) | 3 (60) | 8 (53) | 3 (60) | 8 (57) | 3 (50) | 6 (55) | 3 (60) |
|
| 1.00 | .66 | 1.00 | 1.00 | 1.00 | 1.00 | ||||||
| Full rotations, | 1.3 ± 0.4 | 1.4 ± 0.4 | 1.2 ± 0.4 | 1.2 ± 0.4 | 1.3 ± 0.4 | 1.4 ± 0.3 | 1.3 ± 0.4 | 1.2 ± 0.4 | 1.2 ± 0.4 | 1.3 ± 0.4 | 1.6 ± 0.7 | 1.7 ± 0.4 |
|
| .61 | 1.00 | .44 | .57 | .83 | .59 | ||||||
| Cycle length, msec | 144 ± 19 | 149 ± 17 | 168 ± 11 | 172 ± 9 | 192 ± 21 | 188 ± 21 | 166 ± 10 | 165 ± 8 | 157 ± 12 | 163 ± 9 | 156 ± 8 | 158 ± 6 |
|
| .76 | .31 | .60 | 1.00 | .36 | .50 |
LA, left atrium; LSPV, left superior pulmonary vein; NEEES, noninvasive epicardial and endocardial electrophysiology system; RA, right atrium; RSPV, right superior pulmonary vein.
NEEES vs catheter.
Fisher's exact test.
Chi‐square test.
Mann–Whitney U test.